Provexis Share Discussion Threads

[redprince] 24/1/2023 12:28

Well todays RNS is welcomed by me (and the market it would seem) in that the newly granted options are exerciseable from 1 April 2025 until 10 years thereafter which
implies that there is no intention to sell the company or its IP for the foreseeable.That should put an end to baseless talk about being bought out by DSM/By-Health or anyone else?

[redprince] 23/1/2023 09:34

Informer - DSM have been a massive disappointment with the ball being dropped many times in terms of lack of continuity (people shifting) and perceived intransigence wrt the granting of exclusivity.They have not landed one meaningful deal throughout the entire life of the AA - an appalling fact.

I have given up any hope of DSM landing anything meaningful for us.

[informer] 20/1/2023 22:30

Refer DSM.com who having failed miserably to capitalise on the basic Cardiovascular benefits of Fruitflow are now looking to promote sales of Fruitflow demonstrating that this new platform demonstrates DSM's capabilities as an end-to-end purpose-led partner with an innovative range of solutions that enhance gut health to support immunity, digestion, brain health, stress management, metabolic health and more.

Not so sure we will get rich by DSMs contribution to global sales but any positive news greatly received and another string to the bow - Gut Microbiota ?

[winner31] 30/12/2022 11:08

Did they (let us go )! or did we walk away from DSM ,let’s be honest they were lacklustre to say the least .

[redprince] 30/12/2022 10:33

winner31 - if it was a global do you think DSM would have let us go that easily?
Previously they have mentioned parts of global businesses - no mention of that here.

Just the usual cut n paste with the exception that the new agreement is more profitable than the previous one - incrementally so over a number of years.

I am genuinely of the opinion that DSM dropped the ball on FF long ago and probably more than once.The lack of exclusivity cost us the only (non PXS) customer in the UK that ever bought FF.What did we get in their place - nothing whatsoever.

[winner31] 30/12/2022 10:06

Slight change in the wording in this paragraph, · A number of DSM's customers for Fruitflow which are set to be transferred to Provexis have been Fruitflow customers for several years, including some distributor customers which sell Fruitflow on to third parties. The Company has been progressing these sales relationships since the Transfer of Business agreement was announced in June 2022, and confirms it will be able to generate new customers for Fruitflow outside the royalty arrangements with DSM, in addition to its existing supply and distribution agreement for Fruitflow with By-Health’ let’s hope it’s a global

[redprince] 30/12/2022 09:17

No surprise that of the 8 studies By-Health have undertaken only 5 are completed.They say that By-health are working on their SAMR application.How far they can progress with that with 3 studies yet to complete is anyone's guess?

Did read that under the new agreement with DSM with like for like sales we would be "materially better off".
Can only be positive?

No detail on funding or future sales force operation.

Going to be a long wait for the Chinese - 3 studies yet to complete - that could take much of this year and the SAMR as it is a new organisation is likely to take a very considerable length of time with it being new.

Genuinely doubt we will see a single By-Health product get to market in 2023.

As ever they are deliberately vague and the usual cut n paste carp from the last 12 years or more.

[gix er] 22/12/2022 08:57

redprince, you maybe right and I possibly did quote 1-2 years but that was a while ago and for the Blue Cap approval process. Since then SAMR have reduced the time it takes for Blue Cap significantly.
What By-Health will be submitting is for a new permitted health function claim and this is what hasn't been done before so no way to tell how long it will take.

I agree that any new product from By-Health in China could still be some time away but hopefully we will still see some revenue from them as from the 1st of January they will be a distributor of Fruitflow.

[redprince] 22/12/2022 07:58

gix er - i take your point about the SAMR being new process but i remember reading on one of the bb's (it may have been yourself) about the approximate time it took to approve a claim under the old system and from memory it was 1 - 2 years?

My point is that anyone thinking that the SAMR approval is going to be a few months is almost certainly going to be disappointed.As it is new it is likely it will take a considerable time as they have not done it before.

Before they even submit we need the rns confirming that all trials are complete and the SAMR submission is a go.

Remember we were originally told we could expect By-Health products in the market place by end of 2017 so i am not expecting any sudden change in the speed of things here as neither the Chinese regulatory authorities nor By-Health are going to be rushed on account of us Pixie shareholders!!!!

I actually doubt if we will see any products launched by end of q3 2023 but ofc i hope i am wrong about that.

[gix er] 21/12/2022 11:22

IMO nobody can estimate how long the "new permitted health function claim" will take as no organization or individual has actually done it yet as far as I can tell. Then there is Blue Cap for products. I think this can run side by side to the new health function claim but who knows.

As for DSM, well I don't think they did as much as they could have when it came to sales.

[redprince] 21/12/2022 09:29

Bareknee - i agree.Actually it would be folly to start spending money we don't have on a skill set we dont have.They will as you say if anything outsource but that is unlikely to bear much if any fruit for the reason you gave.

We can expect the usual cut n paste about prospepctive interest from parts of global businesses and how the By-Health deal has potential for sales at a multiple of existing sales and all the usual blather that Buck writes.

Hopefully we get confirmation that the clinical trials are complete with no more being added on at this stage.Then it is what i expect to be a lengthy SAMR submission
which i dont expect to be finished for at least 9 months despite what others may (wishfully think).

[bareknee] 20/12/2022 20:12

I'm not expecting much news on the Sales Force side, I'll be surprised if we do much beyond what Ford himself will do on sales, probably with some part-time assistance from third parties.

I suspect the plan will be to keep existing customers, bring on some of the current pipeline and wait to see what happens with By-Health.

If DSM couldn't drum up large amounts of business in Europe, the Americas and Asia, there's no reason I can see that an in-house team would do any better.

BB

[redprince] 02/11/2022 08:46

I am thinking this could be a good move - DSM clearly let the ball drop on sales effort and we did not get told what was going on.If we have our own sales team then they will be accountable to us.

Also we make more from a profit % angle under the new arrangement from next year.

I expect to hear a lot at the end of the year regarding financing, the new sales force and hopefully on By-Health's completion of all trials.Then it is countdown to Blue-Hat approval although no one seems to know how long that will take - many months at the least.

[winner31] 10/10/2022 15:29

Let’s hope so

[horridhenry] 10/10/2022 13:25

cash call coming - they will be recruiting a sales team very soon

[nestoframpers] 04/10/2022 13:36

443 spot on.

[redprince] 30/9/2022 11:02

Yes HH Moon is doing what he excels at - losing other people's money and by all accounts driving away good talent from the business.

He seems to excel at both.

[horridhenry] 30/9/2022 10:23

Looks like Moon is doing his magic at SIS too
What a pillock

[redprince] 30/9/2022 07:57

I am almost incredulous and dismayed that after 13 or 14 years we have not signed a major name and are dependant solely on a deal with a Chinese entity who are in no rush to get this over the line if they ever do.

To think that at one point Unilever and CC were interested and the company lost their interest because of a lack of willingness to grant exclusivity and MM walked away for same reasons putting the kybosh on a major UK National launch of a shot format product and we have what?Not one meaningful deal anywhere.

The company was used as a vehicle for a former director to acquire a sports drink outfit that was never right for Pxs and did so after he had caused a sell off in our stock value thereby making the rushed through deal much more dilutive than it needed to be.

Yet we have directors who have earned millions (literally) for managing this tragedy overseeing a collapse in shareholder value and a company that champions reduced losses after 14 years and whose t/o is less than a kebab shop on Tottenham High road.

Risible.

[redprince] 30/9/2022 07:03

Well in the final results they tell us that they expect to need either loan finance or yet another dilutive equity raise to purchase DSM's remaining stock of FF at year end/early next year.

The company that never fails to disappoint.

Not one meaningful deal done in over 13 years and same old cut and paste.

They trumpet reduced losses as though it was something to be proud of - companies are meant to be run to return shareholders value.


Unreal - i do hope that our largest shareholder is holding them to task as no one else will.

Queue the date for the agm where the pi's will sit in a room half full of paid associates and be fed the same "nudge nudge if only you knew what we knew TTNY" bs that they have been feeding us for 13 years now.

Rant over.

[redprince] 11/9/2022 12:08

Six figure bod remuneration for a company with a turnover like ours is contemptible.

IF actually has allegedly declined to speak to certain shareholders due to their cynicism regarding the running of this co.

The pi's should have demanded better long ago - i did try but all i got was excuses.

Yes the agm will be postponed until the last possible moment and the results will be the same.

Expect more of the last 13 year rinse and repeat with the usual suspects falling for it all hook line and sinker.

[winner31] 10/9/2022 13:23

You forgot “· Planned launch by By-Health, a circa £5bn listed Chinese dietary supplement business, of a number of Fruitflow based products in the Chinese market is progressing well. Potential sales volumes remain at a significant multiple of existing Fruitflow sales.”

[redprince] 08/9/2022 09:19

Provexis website states that the AGM will be September - i predict the following:

~it wont be in September and they have not bothered changing this yet just like last year

~the annual report will talk again about talks with parts of global businesses
~more talk of potential for significant multiples of current income

~there will be no roadmap discussed as there never is
~record low losses

~director pay will increase as it has always had a distinctly inverse linear relationship to profitability and shareholder value

~ the few genuine holders who attend will be fobbed off with the recurring TTNY (if only you knew what we know) chat and will all leave feeling temporarily happier

~ the agm will have at least as many paid associates/marketeers/consultants as shareholders

There is a chance that we will actually get By-Health product to market in 2023 but i would not bank on it - this was meant to have happened by end of 2017.

AIMHO.DYOR.